Poor Quality of Life in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and their Predictive Factors

CHEST Journal ◽  
2004 ◽  
Vol 126 (4) ◽  
pp. 841S
Author(s):  
Zhenying Cao ◽  
Wan Cheng Tan ◽  
Philip Eng ◽  
Tze Pin Ng ◽  
Kian Chung Ong
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Acute Exacerbation ◽  
Predictive Factors ◽  
Poor Quality ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease

scholarly journals The de Morton mobility index is a feasible and valid mobility assessment tool in hospitalized patients with an acute exacerbation of chronic obstructive pulmonary disease

2019 ◽  
Vol 16 ◽  
pp. 147997311987297 ◽  
Author(s):  
Pat G Camp ◽  
Carmen A Sima ◽  
Ashley Kirkham ◽  
Jessica A Inskip ◽  
Beena Parappilly
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Acute Exacerbation ◽  
Hospitalized Patients ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Mobility Index ◽  
Group Validity

There is no accepted standard for measuring mobility in hospitalized patients with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The objective of this study was to assess convergent, discriminant, and known-group validity and floor/ceiling effects of the de Morton Mobility Index (DEMMI) in hospitalized patients with AECOPD. Individuals with AECOPD ( n = 22) admitted to an acute care hospital medical ward were recruited. Data on the DEMMI, gait speed, daytime energy expenditure, step counts, 6-minute walk distance (6MWD), dyspnea, respiratory and heart rates, quality of life, and oxygen supplementation were collected on day 3 of admission. The DEMMI demonstrated convergent validity with the 6MWD and gait velocity measures (Spearman’s ρ 0.69 and 0.61, respectively; p < 0.003) but not with measures of physical activity or respiratory impairment. Discriminant validity was present, with no correlation between the DEMMI and quality of life and resting heart rate. Known-group validity (gait aids vs. no gait aids) was demonstrated ( p = 0.009). There was no floor effect but there was evidence of a possible ceiling effect (14% of participants received a perfect score). The DEMMI is feasible and showed moderate to strong validity with measures of observed physical function in hospitalized patients with AECOPD.

scholarly journals Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)

BMJ Open ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. e043014
Author(s):  
Klaus Kenn ◽  
Rainer Gloeckl ◽  
Daniela Leitl ◽  
Tessa Schneeberger ◽  
Inga Jarosch ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Acute Exacerbation ◽  
Hospital Admissions ◽  
Negative Impact ◽  
Chronic Obstructive ◽  
Detailed Knowledge ◽  
Obstructive Pulmonary Disease

IntroductionAcute exacerbations of chronic obstructive pulmonary disease (AECOPD) are the most critical events for patients with COPD that have a negative impact on patients’ quality of life, accelerate disease progression, and can result in hospital admissions and death. Although there is no distinct definition or detailed knowledge about AECOPD, it is commonly used as primary outcome in clinical studies. Furthermore, it may be difficult in clinical practice to differentiate the worsening of symptoms due to an AECOPD or to the development of heart failure. Therefore, it is of major clinical importance to investigate the underlying pathophysiology, and if possible, predictors of an AECOPD and thus to identify patients who are at high risk for developing an acute exacerbation.Methods and analysisIn total, 355 patients with COPD will be included prospectively to this study during a 3-week inpatient pulmonary rehabilitation programme at the Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee (Germany). All patients will be closely monitored from admission to discharge. Lung function, exercise tests, clinical parameters, quality of life, physical activity and symptoms will be recorded, and blood samples and exhaled air will be collected. If a patient develops an AECOPD, there will be additional comprehensive diagnostic assessments to differentiate between cardiac, pulmonary or cardiopulmonary causes of worsening. Follow-up measures will be performed at 6, 12 and 24 months.Exploratory data analyses methods will be used for the primary research question (screening and identification of possible factors to predict an AECOPD). Regression analyses and a generalised linear model with a binomial outcome (AECOPD) will be applied to test if predictors are significant.Ethics and disseminationThis study has been approved by the Ethical Committee of the Philipps University Marburg, Germany (No. 61/19). The results will be presented in conferences and published in a peer-reviewed journal.Trial registration numberNCT04140097.

scholarly journals Quality of life in patients with chronic obstructive pulmonary disease at Pulmonary Community Health Centre Makassar

2018 ◽  
Vol 5 (9) ◽  
pp. 3753
Author(s):  
Elva Cristy Irianti ◽  
Arsunan A. A. ◽  
M. Tahir Abdullah
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Multivariate Analysis ◽  
Community Health ◽  
Pulmonary Disease ◽  
Poor Quality ◽  
Chronic Obstructive ◽  
Quality Of Sleep ◽  
Obstructive Pulmonary Disease

Background: Chronic obstructive pulmonary disease (COPD) that causes damage to lung conditions such as dyspnea that affects to social and psychological life of the sufferer which overall affects the quality of life. This reaserch aims to focuses on factors related to the quality of life patients with COPD at the Pulmonary Community Health Center, Makassar.Methods: This study used cross sectional study design. Population in this research were patients with COPD who undergo treatment period of October-December 2017 that was as much as 381. Sampling was done by consecutive sampling with total sampel 160 responden. Data analysis consisted of univariate, bivariate with chi square test and multivariate analysis with logistic regression.Results: The results showed that some respondents had poor quality of life (63.8%) and other respondents had a good quality of life (36.3%). Factors related to quality of life were the severity of COPD (p=0.028), comorbidity (p=0.001) and quality of sleep (p=0.005). A multivariate analysis showed that patients with comorbidity were at risk 2,716 times to have poor quality of life.Conclusions: The severity of COPD, comorbidity and quality of sleep were related to have poor quality of life. Patients with COPD should early diagnosis of severity and should change their lifestyle better so as not to aggravate the quality of life.

scholarly journals Safety and efficacy of inpatient pulmonary rehabilitation for patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease: a systematic review protocol

BMJ Open ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. e043377
Author(s):  
Kai Zhu ◽  
Jagdeep Gill ◽  
Ashley Kirkham ◽  
Joel Chen ◽  
Amy Ellis ◽  
...  
Keyword(s):  
Systematic Review ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Acute Exacerbation ◽  
Pulmonary Rehabilitation ◽  
Meta Analysis ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Safety And Efficacy

IntroductionPulmonary rehabilitation (PR) following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) reduces the risk of hospital admissions, and improves physical function and health-related quality of life. However, the safety and efficacy of in-hospital PR during the most acute phase of an AECOPD is not well established. This paper describes the protocol for a systematic review with meta-analysis to determine the safety and efficacy of inpatient acute care PR during the hospitalisation phase.Methods and analysisMedical literature databases and registries MEDLINE, EMBASE, Physiotherapy Evidence Database, Cumulative Index to Nursing and Allied Health Literature, Canadian Agency for Drugs and Technologies in Health, CENTRAL, Allied and Complementary Medicine Database, WHO trials portal and ClinicalTrials.gov will be searched for articles from inception to June 2021 using a prespecified search strategy. We will identify randomised controlled trials that have a comparison of in-hospital PR with usual care. PR programmes had to commence during the hospitalisation and include a minimum of two sessions. Title and abstract followed by full-text screening will be conducted independently by two reviewers. A meta-analysis will be performed if there is sufficient homogeneity across selected studies or groups of studies. The Population, Intervention, Comparator, Outcomes and Study characteristics framework will be used to standardise the data collection process. The quality of the cumulative evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations framework.Ethics and disseminationAECOPD results in physical limitations which are amenable to PR. This review will assess the safety and efficacy of in-hospital PR for AECOPD. The results will be presented in a peer-reviewed publication and at research conferences. Ethical review is not required for this study.

Sign in / Sign up

Export Citation Format

Share Document